Bioidentical hormones vs standard HRT: what is the difference?

Short answer

• “Bioidentical” hormones have the same chemical structure as hormones made naturally in the human body (for example, estradiol or micronized progesterone).
• “Standard” HRT usually refers to conventional, FDA‑approved hormone therapies — some of which are not bioidentical (for example, conjugated equine estrogens or synthetic progestins).
• There is no clear high‑quality evidence that custom‑compounded “bioidentical hormone therapy” is safer or more effective than FDA‑approved HRT. FDA‑approved products give consistent dosing, purity and safety data; compounded products can vary in potency and are less regulated.

Definitions and types

• Bioidentical hormones: molecules that are chemically identical to human hormones (estradiol, progesterone, testosterone). Can be supplied as FDA‑approved, bioidentical products (e.g., estradiol, micronized progesterone) or made by compounding pharmacies into custom formulations.
• Standard HRT: broad term for conventional therapies used for menopausal symptoms and other hormone deficiencies. Includes:
  • FDA‑approved bioidentical products (e.g., estradiol tablets/patches, micronized progesterone)
  • Non‑bioidentical/synthetic or animal‑derived products (e.g., conjugated equine estrogens—Premarin; medroxyprogesterone acetate—Provera)

Safety, quality and evidence — key differences

• Regulation and quality control: FDA‑approved products (brands below) are manufactured under strict standards, have labeled dosing and safety data. Compounded bioidentical preparations are made per prescription by compounding pharmacies and are not FDA‑approved; potency and purity can be inconsistent.
• Evidence base: large randomized trials and observational data exist for many FDA‑approved regimens; evidence that compounded BHRT reduces risk (breast cancer, heart disease, clots) is lacking. Medical societies (ACOG, Endocrine Society) and the FDA recommend caution with compounded BHRT except when a medically necessary, FDA‑approved option is not available.
• Testing and dosing claims: “Hormone testing” using saliva panels to customize dosing is not supported by strong evidence. Blood levels are sometimes useful for specific hormones (e.g., testosterone), but symptom control and risk factors guide therapy more than routine level chasing.
• Safety profile: risks (VTE, stroke, breast cancer, cardiovascular effects) depend on hormone type, dose, route (oral vs transdermal vs vaginal), duration, and individual risk factors. For example, transdermal estradiol may have lower VTE risk than some oral estrogens.

Routes matter

• Transdermal (patch, gel) vs oral: transdermal avoids first‑pass liver metabolism and may have lower effects on clotting factors and triglycerides.
• Vaginal products: useful for local genitourinary symptoms with low systemic exposure.

Examples of FDA‑approved products (to discuss with your clinician)

• Estradiol (oral): Estrace (oral estradiol)
• Estradiol patches/systems: Vivelle‑Dot, Climara, Alora, Minivelle (transdermal estradiol patches)
• Vaginal ring/creams: Estring (vaginal ring), Premarin vaginal cream (note Premarin systemic form is conjugated equine estrogens)
• Micronized progesterone (bioidentical, oral): Prometrium — an FDA‑approved bioidentical progesterone often used when a progestogen is needed.
• Non‑bioidentical examples: Premarin (conjugated equine estrogens), Provera (medroxyprogesterone acetate)
• Testosterone for women/men: AndroGel, Testim, Depo‑Testosterone (all are prescription FDA products for appropriate indications)

If considering compounded bioidentical hormones

• Use only a reputable, accredited compounding pharmacy (look for PCAB/URAC accreditation and state licensure) and ask about third‑party testing.
• Understand insurance often won’t cover compounded products and formulations may not be standardized.
• Compounded options may be appropriate only when an FDA‑approved formulation doesn’t meet a patient’s specific medical need (allergy to an ingredient, unavailable dose or form).

Practical guidance

• Talk with a clinician experienced in menopause or endocrinology. Describe symptoms, medical history, family history (breast/ovarian/blood clots), and preferences.
• Prefer FDA‑approved options when available. If you want “bioidentical” hormones, ask whether an FDA‑approved bioidentical product (for example, estradiol or Prometrium) will meet your needs.
• Use the lowest effective dose for symptom control and have regular follow‑up to reassess risks and benefits.
• Be wary of clinics or products that claim “natural = safe” or push saliva testing for dosing.

Where to read more

• FDA’s page on “Beware of Compounded ‘Bioidentical’ Hormone Therapy”
• ACOG and Endocrine Society clinical practice statements on hormone therapy and compounded HRT

If you want, tell me: are you asking about menopause symptoms, low testosterone, or another situation? I can then outline likely FDA‑approved options and what to ask your clinician.